terclim by ICS banner
IVES 9 IVES Conference Series 9 International Congress on Grapevine and Wine Sciences 9 2ICGWS-2023 9 Moderate wine consumption – part of a balanced diet or a health risk?

Moderate wine consumption – part of a balanced diet or a health risk?

Abstract

Consumption of wine/alcoholic beverages remains a topic of great uncertainty and controversy worldwide.  The term “no safe level” dominates the media communication and policy ever since population studies in 2018 [1,2] were published, which denied the existence of a J-curve and suggested that ANY consumption of an alcoholic beverage is harmful to health. The scientific evidence accumulated during the past decades about the health benefits of moderate wine consumption, were questioned and drinking guidelines considered to be too loose. As a consequence, during the last few years, the upper limit of low-risk alcohol consumption has been progressively lowered in the national drinking guidelines. 

Although the authors of the Global Burden of Disease (GBD) study concluded in 2018 that it would be best for overall health to avoid drinking at all, the same GBD scientists in 2022, corrected their own previous data.  In their 2022 update [3] – different from the 2018 publication – the alcohol-related health risks in every country were considered. The results showed that the risks from the consumption of alcoholic beverages vary greatly depending on the disease, age and region. Based on these new results, a moderate consumption of wine/alcoholic beverages for individuals above 40 years of age can provide health benefits, such as a lower risk of cardiovascular diseases and diabetes. The influence of moderate wine/alcohol consumption on health was described by a J-shaped curve. Excessive drinking is always associated with an increased risk of death and various health risks.

What are the reasons for such contrary results and what is the practical significance of “global calculations” in both GBD studies?  What does it mean for the wine consumer? The latest scientific evidence of moderate wine consumption in the context a healthy lifestyle and diet will be discussed, as well as how the communication of the Wine in Moderation initiative builds on objective scientific facts.

  1. Gakidou, E.,(2018) Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 392(10152):1015-1035 DOI: https://doi.org/10.1016/S0140-6736(18)31310-2
  2. Wood, A.M., et al., Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet, 2018. 391(10129):1513-1523 DOI: https://doi.org/10.1016/S0140-6736(18)30134-X
  3. Gakidou, E. and G.A. Collaborators, Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet, 2022. 400(10347):185-235 DOI: https://doi.org/10.1016/S0140-6736(22)00847-9.

DOI:

Publication date: October 19, 2023

Issue: ICGWS 2023

Type: Article

Authors

Ursula Fradera1

1Deutsche Weinakademie, Platz des Weines 2, 55294 Bodenheim, Germany

Contact the author*

Keywords

alcohol, wine, benefits, health risks, global burden of disease

Tags

2ICGWS | ICGWS | ICGWS 2023 | IVES Conference Series

Citation

Related articles…

Effect on the grape and wine characteristics of cv. Tempranillo at 3 production levels

The vineyard has experienced a general increase in yields mainly due to the elevated use of technology which caused a quality loss of grapes in more than one case. A large percentage of the Spanish vineyard is covered by a Denomination of Origin which limits the productive level of the vineyards as one of its regulations. The maximum production limit is a variable characteristic of each vineyard and is not usually regulated by agronomic criteria, and this explains the fact that each vineyard can reach high quality with a totally different yield from that set by the Denomination of Origin.

Crown procyanidin quantification in red wines, rosé wines and Port wines

Condensed grape tannins play a major role in the organoleptic properties and quality of red wine. Recently, a new sub-family of macrocyclic condensed tannins has been identified in red wine and named “crown tannins”. Indeed, the first compound of the family identified and characterised by NMR was the crown procyanidin tetramer which is composed of a macrocyclic structure composed of four (-)-epicatechins link together by B-type interflavanoid linkage in the following an alternative sequences of C4-C8 and C4-C6 linkage. The 3D structure of this unusual crown procyanidin family reveals a central cavity in the molecule [1].

Evaluation of Furmint clones in the Tokaj Wine Region

The ’Furmint’ is the most important grape variety in the Tokaj Wine Region, constituting around 65% of its vineyard area. Before the phylloxera disease many types were grown, but as selection started in the 20th century, its diversity dramatically narrowed. As a result, the cultivation of Furmint was based mainly on two heavy-cropping clones, T.85 and T.92 at the end of the ’80s. Aims of present clone research take into account that after solely quantity as target, quality emerged in the 1990’s and most recently, typicity appeared as more private estates began their own selection program.

Ability of lactic acid bacterial laccases to degrade biogenic amines and OTA in wine

Two of the most harmful microbial metabolites for human health that can be present in wines and either fermented or raw foods are biogenic amines (BA) and ochratoxine A (OTA). Winemakers are aware of the need to avoid their presence in wine by using different strategies, one of them is the use of enzymes. Some recombinant laccases have been characterized and revealed as potential tools to degrade these toxic compounds in wine[1], specifically biogenic amines[2].

Grape pomace, an active ingredient at the intestinal level: Updated evidence

Grape pomace (GP) is a winemaking by-product particularly rich in (poly)phenols and dietary fiber, which are the main active compounds responsible for its health-promoting effects. GP-derived products have been proposed to manage cardiovascular risk factors, including endothelial dysfunction, inflammation, hypertension, hyperglycemia, and obesity. Studies on the potential impact of GP on gut health are much more recent. However, it is suggested that, to some extent, this activity of GP as a cardiometabolic health-promoting ingredient would begin in the gastrointestinal tract as GP components (i.e., (poly)phenols and fiber) undergo extensive catabolism, mainly by the action of the intestinal microbiota, that gives rise to low-molecular-weight bioactive compounds that can be absorbed and utilized by the body.